Skip to NavigationSkip to content

News

0
Novartis has revealed new interim data from its Phase 3 trial investigating the efficacy of its gene therapy Zolgensma in the treatment of spinal...
0
-Gilead to lay off one fifth of sales force -GSK to make redundancies at plant in Stevenage -Genentech employee awarded $250,000 over racial...
0
NICE has announced its decision to recommend UCB Pharma’s Cimzia for use on the NHS in England in the treatment of severe plaque psoriasis in...
0
Cannabidiol (CBD), one of 113 cannabinoids in cannabis plants, could be used to deliver medicines into the brain, according to research published...

Features

Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research...